10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001628280-24-047908 |
| Period End Date | 20240930 |
| Filing Date | 20241114 |
| Fiscal Year | 2024 |
| Fiscal Period | Q3 |
| XBRL Instance | swkh-20240930_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
184 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$11.85M | USD | Point-in-time |
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$11.85M | USD | Point-in-time |
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$11.33M | USD | Point-in-time |
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$11.33M | USD | Point-in-time |
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$14.34M | USD | Point-in-time |
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$14.34M | USD | Point-in-time |
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$13.90M | USD | Point-in-time |
| Financing receivable, allowance for credit loss excluding accrued interest |
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
$13.90M | USD | Point-in-time |
| Preferred stock, par or stated value per share (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, par or stated value per share (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, par or stated value per share (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, par or stated value per share (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Preferred stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
5.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$4.50M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$4.50M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$17.18M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$17.18M | USD | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Restricted cash |
RestrictedCashEquivalentsCurrent
|
$733.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashEquivalentsCurrent
|
$733.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashEquivalentsCurrent
|
- | USD | Point-in-time |
| Restricted cash |
RestrictedCashEquivalentsCurrent
|
- | USD | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Interest, accounts receivable and other receivables, net |
AccountsReceivableNet
|
$6.42M | USD | Point-in-time |
| Interest, accounts receivable and other receivables, net |
AccountsReceivableNet
|
$6.42M | USD | Point-in-time |
| Interest, accounts receivable and other receivables, net |
AccountsReceivableNet
|
$4.73M | USD | Point-in-time |
| Interest, accounts receivable and other receivables, net |
AccountsReceivableNet
|
$4.73M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$1.90M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$1.90M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$1.61M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$1.61M | USD | Point-in-time |
| Common stock, par or stated value per share (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par or stated value per share (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par or stated value per share (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par or stated value per share (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$11.87M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$11.87M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$25.21M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$25.21M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
250.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
250.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
250.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
250.00M | shares | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$265.10M | USD | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$265.10M | USD | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$255.90M | USD | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$255.90M | USD | Point-in-time |
| Common stock, shares, issued (in shares) |
CommonStockSharesIssued
|
12.50M | shares | Point-in-time |
| Common stock, shares, issued (in shares) |
CommonStockSharesIssued
|
12.50M | shares | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$260.89M | USD | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$260.89M | USD | Point-in-time |
| Common stock, shares, issued (in shares) |
CommonStockSharesIssued
|
12.26M | shares | Point-in-time |
| Common stock, shares, issued (in shares) |
CommonStockSharesIssued
|
12.26M | shares | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$274.50M | USD | Point-in-time |
| Finance receivables, net of allowance for credit losses of $14,343 and $13,901 as of September 30, 2024 and December 31, 2023, respectively |
NotesAndLoansReceivableNetNoncurrent
|
$274.50M | USD | Point-in-time |
| Collateral on foreign currency forward contract |
CollateralOnForeignCurrencyForwardContract
|
$2.75M | USD | Point-in-time |
| Collateral on foreign currency forward contract |
CollateralOnForeignCurrencyForwardContract
|
$2.75M | USD | Point-in-time |
| Collateral on foreign currency forward contract |
CollateralOnForeignCurrencyForwardContract
|
$2.75M | USD | Point-in-time |
| Collateral on foreign currency forward contract |
CollateralOnForeignCurrencyForwardContract
|
$2.75M | USD | Point-in-time |
| Common stock, shares, outstanding (in shares) |
CommonStockSharesOutstanding
|
12.26M | shares | Point-in-time |
| Common stock, shares, outstanding (in shares) |
CommonStockSharesOutstanding
|
12.26M | shares | Point-in-time |
| Common stock, shares, outstanding (in shares) |
CommonStockSharesOutstanding
|
12.50M | shares | Point-in-time |
| Common stock, shares, outstanding (in shares) |
CommonStockSharesOutstanding
|
12.50M | shares | Point-in-time |
| Marketable investments |
EquitySecuritiesFvNiCost
|
$48.00K | USD | Point-in-time |
| Marketable investments |
EquitySecuritiesFvNiCost
|
$48.00K | USD | Point-in-time |
| Marketable investments |
EquitySecuritiesFvNiCost
|
$755.00K | USD | Point-in-time |
| Marketable investments |
EquitySecuritiesFvNiCost
|
$755.00K | USD | Point-in-time |
| Deferred tax assets, net |
DeferredIncomeTaxAssetsNet
|
$28.29M | USD | Point-in-time |
| Deferred tax assets, net |
DeferredIncomeTaxAssetsNet
|
$28.29M | USD | Point-in-time |
| Deferred tax assets, net |
DeferredIncomeTaxAssetsNet
|
$26.19M | USD | Point-in-time |
| Deferred tax assets, net |
DeferredIncomeTaxAssetsNet
|
$26.19M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$1.22M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$1.22M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$2.03M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$2.03M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$1.30M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$1.30M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$1.76M | USD | Point-in-time |
| Warrant assets |
WarrantAssets
|
$1.76M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$6.49M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$6.49M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$220.00K | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$220.00K | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.82M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.82M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$5.44M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$5.44M | USD | Point-in-time |
| Other non-current assets |
OtherAssetsNoncurrent
|
$3.11M | USD | Point-in-time |
| Other non-current assets |
OtherAssetsNoncurrent
|
$3.11M | USD | Point-in-time |
| Other non-current assets |
OtherAssetsNoncurrent
|
$3.41M | USD | Point-in-time |
| Other non-current assets |
OtherAssetsNoncurrent
|
$3.41M | USD | Point-in-time |
| Total assets |
Assets
|
$334.25M | USD | Point-in-time |
| Total assets |
Assets
|
$334.25M | USD | Point-in-time |
| Total assets |
Assets
|
$321.28M | USD | Point-in-time |
| Total assets |
Assets
|
$321.28M | USD | Point-in-time |
| Total assets |
Assets
|
$321.00M | USD | Point-in-time |
| Total assets |
Assets
|
$321.00M | USD | Point-in-time |
| Total assets |
Assets
|
$321.96M | USD | Point-in-time |
| Total assets |
Assets
|
$321.96M | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$2.87M | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$2.87M | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$3.94M | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$3.94M | USD | Point-in-time |
| Deferred income |
ContractWithCustomerLiabilityCurrent
|
$2.11M | USD | Point-in-time |
| Deferred income |
ContractWithCustomerLiabilityCurrent
|
$2.11M | USD | Point-in-time |
| Deferred income |
ContractWithCustomerLiabilityCurrent
|
$9.00K | USD | Point-in-time |
| Deferred income |
ContractWithCustomerLiabilityCurrent
|
$9.00K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$3.94M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$3.94M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$4.98M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$4.98M | USD | Point-in-time |
| Contingent consideration payable |
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
|
- | USD | Point-in-time |
| Contingent consideration payable |
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
|
- | USD | Point-in-time |
| Contingent consideration payable |
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
|
$4.90M | USD | Point-in-time |
| Contingent consideration payable |
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
|
$4.90M | USD | Point-in-time |
| Unsecured senior notes, net |
UnsecuredLongTermDebt
|
$30.78M | USD | Point-in-time |
| Unsecured senior notes, net |
UnsecuredLongTermDebt
|
$30.78M | USD | Point-in-time |
| Unsecured senior notes, net |
UnsecuredLongTermDebt
|
$31.24M | USD | Point-in-time |
| Unsecured senior notes, net |
UnsecuredLongTermDebt
|
$31.24M | USD | Point-in-time |
| Revolving credit facility |
LongTermLineOfCredit
|
$12.35M | USD | Point-in-time |
| Revolving credit facility |
LongTermLineOfCredit
|
$12.35M | USD | Point-in-time |
| Revolving credit facility |
LongTermLineOfCredit
|
- | USD | Point-in-time |
| Revolving credit facility |
LongTermLineOfCredit
|
- | USD | Point-in-time |
| Other non-current liabilities |
OtherLiabilitiesNoncurrent
|
$1.96M | USD | Point-in-time |
| Other non-current liabilities |
OtherLiabilitiesNoncurrent
|
$1.96M | USD | Point-in-time |
| Other non-current liabilities |
OtherLiabilitiesNoncurrent
|
$1.62M | USD | Point-in-time |
| Other non-current liabilities |
OtherLiabilitiesNoncurrent
|
$1.62M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$53.94M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$53.94M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$37.85M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$37.85M | USD | Point-in-time |
| Commitments and contingencies (Note 6) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 6) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 6) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 6) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.001 par value; 250,000,000 shares authorized; 12,263,982 and 12,497,770 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively |
CommonStockValue
|
$12.00K | USD | Point-in-time |
| Common stock, $0.001 par value; 250,000,000 shares authorized; 12,263,982 and 12,497,770 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively |
CommonStockValue
|
$12.00K | USD | Point-in-time |
| Common stock, $0.001 par value; 250,000,000 shares authorized; 12,263,982 and 12,497,770 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively |
CommonStockValue
|
$12.00K | USD | Point-in-time |
| Common stock, $0.001 par value; 250,000,000 shares authorized; 12,263,982 and 12,497,770 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively |
CommonStockValue
|
$12.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$4.42B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$4.42B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$4.43B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$4.43B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-4.14B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$277.56M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$277.56M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$273.88M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$273.88M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$274.38M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$274.38M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$279.93M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$279.93M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$280.31M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$280.31M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$283.43M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$283.43M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$282.83M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$282.83M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$279.89M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$279.89M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$321.28M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$321.28M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$334.25M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$334.25M | USD | Point-in-time |
Income Statement
256 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$9.99M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$9.99M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$11.04M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$11.04M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$8.61M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$8.61M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$27.15M | USD | 3 Qtrs |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$27.15M | USD | 3 Qtrs |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$9.50M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$9.50M | USD | 1 Quarter |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$21.02M | USD | 2 Qtrs |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$21.02M | USD | 2 Qtrs |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$30.52M | USD | 3 Qtrs |
| Finance receivable interest income, including fees |
InterestAndFeeIncomeLoansAndLeases
|
$30.52M | USD | 3 Qtrs |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.71M | USD | 3 Qtrs |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.71M | USD | 3 Qtrs |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$628.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$628.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$315.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$315.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$804.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$804.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$616.00K | USD | 3 Qtrs |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$616.00K | USD | 3 Qtrs |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$279.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$279.00K | USD | 1 Quarter |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.08M | USD | 2 Qtrs |
| Pharmaceutical development |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$1.08M | USD | 2 Qtrs |
| Other |
OtherIncome
|
$108.00K | USD | 3 Qtrs |
| Other |
OtherIncome
|
$108.00K | USD | 3 Qtrs |
| Other |
OtherIncome
|
$103.00K | USD | 2 Qtrs |
| Other |
OtherIncome
|
$103.00K | USD | 2 Qtrs |
| Other |
OtherIncome
|
$46.00K | USD | 1 Quarter |
| Other |
OtherIncome
|
$46.00K | USD | 1 Quarter |
| Other |
OtherIncome
|
$292.00K | USD | 1 Quarter |
| Other |
OtherIncome
|
$292.00K | USD | 1 Quarter |
| Other |
OtherIncome
|
$39.00K | USD | 1 Quarter |
| Other |
OtherIncome
|
$39.00K | USD | 1 Quarter |
| Other |
OtherIncome
|
$395.00K | USD | 3 Qtrs |
| Other |
OtherIncome
|
$395.00K | USD | 3 Qtrs |
| Other |
OtherIncome
|
$57.00K | USD | 1 Quarter |
| Other |
OtherIncome
|
$57.00K | USD | 1 Quarter |
| Total revenues |
Revenues
|
$10.85M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$10.85M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$10.42M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$10.42M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$11.36M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$11.36M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$22.21M | USD | 2 Qtrs |
| Total revenues |
Revenues
|
$22.21M | USD | 2 Qtrs |
| Total revenues |
Revenues
|
$8.96M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$8.96M | USD | 1 Quarter |
| Total revenues |
Revenues
|
$27.87M | USD | 3 Qtrs |
| Total revenues |
Revenues
|
$27.87M | USD | 3 Qtrs |
| Total revenues |
Revenues
|
$32.62M | USD | 3 Qtrs |
| Total revenues |
Revenues
|
$32.62M | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$1.39M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$1.39M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$10.78M | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$10.78M | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$223.00K | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$223.00K | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$4.09M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$4.09M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$5.30M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$5.30M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$9.39M | USD | 2 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$9.39M | USD | 2 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$-459.00K | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$-459.00K | USD | 3 Qtrs |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 1 Quarter |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 1 Quarter |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
$5.77M | USD | 3 Qtrs |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
$5.77M | USD | 3 Qtrs |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 1 Quarter |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 1 Quarter |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 3 Qtrs |
| Loss on impairment of intangibles assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 3 Qtrs |
| Interest expense |
InterestExpenseOperating
|
$721.00K | USD | 3 Qtrs |
| Interest expense |
InterestExpenseOperating
|
$721.00K | USD | 3 Qtrs |
| Interest expense |
InterestExpenseOperating
|
$3.51M | USD | 3 Qtrs |
| Interest expense |
InterestExpenseOperating
|
$3.51M | USD | 3 Qtrs |
| Interest expense |
InterestExpenseOperating
|
$1.14M | USD | 1 Quarter |
| Interest expense |
InterestExpenseOperating
|
$1.14M | USD | 1 Quarter |
| Interest expense |
InterestExpenseOperating
|
$176.00K | USD | 1 Quarter |
| Interest expense |
InterestExpenseOperating
|
$176.00K | USD | 1 Quarter |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$585.00K | USD | 1 Quarter |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$585.00K | USD | 1 Quarter |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$2.83M | USD | 3 Qtrs |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$2.83M | USD | 3 Qtrs |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$1.64M | USD | 3 Qtrs |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$1.64M | USD | 3 Qtrs |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$606.00K | USD | 1 Quarter |
| Pharmaceutical manufacturing, research and development expense |
ResearchAndDevelopmentExpense
|
$606.00K | USD | 1 Quarter |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
- | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
- | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
$-4.90M | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
$-4.90M | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
- | USD | 1 Quarter |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
- | USD | 1 Quarter |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
$4.90M | USD | 1 Quarter |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
$4.90M | USD | 1 Quarter |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
- | USD | 1 Quarter |
| Change in fair value of acquisition-related contingent consideration |
AcquisitionRelatedContingentConsiderationFairValueAdjustment
|
- | USD | 1 Quarter |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.94M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.94M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$652.00K | USD | 1 Quarter |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$652.00K | USD | 1 Quarter |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.17M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.17M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$234.00K | USD | 1 Quarter |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$234.00K | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$8.52M | USD | 3 Qtrs |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$8.52M | USD | 3 Qtrs |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$8.60M | USD | 3 Qtrs |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$8.60M | USD | 3 Qtrs |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$2.98M | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$2.98M | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$2.99M | USD | 1 Quarter |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$2.99M | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$4.33M | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$4.33M | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$14.32M | USD | 3 Qtrs |
| Income from operations |
OperatingIncomeLoss
|
$14.32M | USD | 3 Qtrs |
| Income from operations |
OperatingIncomeLoss
|
$4.08M | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$4.08M | USD | 1 Quarter |
| Income from operations |
OperatingIncomeLoss
|
$6.06M | USD | 3 Qtrs |
| Income from operations |
OperatingIncomeLoss
|
$6.06M | USD | 3 Qtrs |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$-745.00K | USD | 3 Qtrs |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$-745.00K | USD | 3 Qtrs |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$47.00K | USD | 1 Quarter |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$47.00K | USD | 1 Quarter |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$-162.00K | USD | 1 Quarter |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$-162.00K | USD | 1 Quarter |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$178.00K | USD | 3 Qtrs |
| Unrealized net gain (loss) on warrants |
UnrealizedGainLossOnDerivatives
|
$178.00K | USD | 3 Qtrs |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$-6.00K | USD | 1 Quarter |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$-6.00K | USD | 1 Quarter |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 1 Quarter |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 1 Quarter |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 3 Qtrs |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 3 Qtrs |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$12.00K | USD | 3 Qtrs |
| Unrealized net (loss) gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$12.00K | USD | 3 Qtrs |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
$495.00K | USD | 3 Qtrs |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
$495.00K | USD | 3 Qtrs |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
- | USD | 1 Quarter |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
- | USD | 1 Quarter |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
- | USD | 3 Qtrs |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
- | USD | 3 Qtrs |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
- | USD | 1 Quarter |
| Realized gain on sale of marketable investments |
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
- | USD | 1 Quarter |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 3 Qtrs |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 3 Qtrs |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
$-228.00K | USD | 3 Qtrs |
| Realized loss on sale of assets |
GainLossOnDispositionOfAssets1
|
$-228.00K | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 3 Qtrs |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-76.00K | USD | 1 Quarter |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-76.00K | USD | 1 Quarter |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$426.00K | USD | 3 Qtrs |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$426.00K | USD | 3 Qtrs |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$251.00K | USD | 1 Quarter |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$251.00K | USD | 1 Quarter |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$775.00K | USD | 3 Qtrs |
| Realized and unrealized foreign currency transaction gains (losses) |
ForeignCurrencyTransactionGainLossBeforeTax
|
$775.00K | USD | 3 Qtrs |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$9.79M | USD | 3 Qtrs |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$9.79M | USD | 3 Qtrs |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$4.09M | USD | 1 Quarter |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$4.09M | USD | 1 Quarter |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$4.37M | USD | 1 Quarter |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$4.37M | USD | 1 Quarter |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$14.00M | USD | 3 Qtrs |
| Income before income tax expense (benefit) |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$14.00M | USD | 3 Qtrs |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$959.00K | USD | 3 Qtrs |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$959.00K | USD | 3 Qtrs |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$2.17M | USD | 3 Qtrs |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$2.17M | USD | 3 Qtrs |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$906.00K | USD | 1 Quarter |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$906.00K | USD | 1 Quarter |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$-386.00K | USD | 1 Quarter |
| Income tax expense (benefit) |
IncomeTaxExpenseBenefit
|
$-386.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.63M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.63M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$468.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$468.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.93M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.93M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.68M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.68M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.15M | USD | 2 Qtrs |
| Net income |
NetIncomeLoss
|
$4.15M | USD | 2 Qtrs |
| Net income |
NetIncomeLoss
|
$7.62M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$7.62M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$13.04M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$13.04M | USD | 3 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$1.03 | USD | 3 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$1.03 | USD | 3 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.29 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.29 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.36 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.36 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.04 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.04 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.33 | USD | 2 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.33 | USD | 2 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.28 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.28 | USD | 1 Quarter |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.61 | USD | 3 Qtrs |
| Basic (in dollars per share) |
EarningsPerShareBasic
|
$0.61 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.28 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.28 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$1.02 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$1.02 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.04 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.04 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.61 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.61 | USD | 3 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.29 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.29 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.36 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.36 | USD | 1 Quarter |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.33 | USD | 2 Qtrs |
| Diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.33 | USD | 2 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.70M | shares | 3 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.70M | shares | 3 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.32M | shares | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.32M | shares | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.42M | shares | 3 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.42M | shares | 3 Qtrs |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.54M | shares | 1 Quarter |
| Basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
12.54M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.58M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.58M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.41M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.41M | shares | 1 Quarter |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.49M | shares | 3 Qtrs |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.49M | shares | 3 Qtrs |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.75M | shares | 3 Qtrs |
| Diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
12.75M | shares | 3 Qtrs |
Cash Flow Statement
208 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
NetIncomeLoss
|
$4.63M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.63M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$468.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$468.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.93M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.93M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.68M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.68M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.15M | USD | 2 Qtrs |
| Net income |
NetIncomeLoss
|
$4.15M | USD | 2 Qtrs |
| Net income |
NetIncomeLoss
|
$7.62M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$7.62M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$13.04M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$13.04M | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$1.39M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$1.39M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$10.78M | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$10.78M | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$223.00K | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$223.00K | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$4.09M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$4.09M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$5.30M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$5.30M | USD | 1 Quarter |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$9.39M | USD | 2 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$9.39M | USD | 2 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$-459.00K | USD | 3 Qtrs |
| Provision (benefit) for credit losses |
ProvisionForOtherCreditLosses
|
$-459.00K | USD | 3 Qtrs |
| Loss on impairment of intangible assets |
ImpairmentOfIntangibleAssetsFinitelived
|
- | USD | 3 Qtrs |
| Loss on impairment of intangible assets |
ImpairmentOfIntangibleAssetsFinitelived
|
- | USD | 3 Qtrs |
| Loss on impairment of intangible assets |
ImpairmentOfIntangibleAssetsFinitelived
|
$5.77M | USD | 3 Qtrs |
| Loss on impairment of intangible assets |
ImpairmentOfIntangibleAssetsFinitelived
|
$5.77M | USD | 3 Qtrs |
| Right-of-use amortization and cease use costs |
FinanceLeaseRightOfUseAssetAmortization
|
$244.00K | USD | 3 Qtrs |
| Right-of-use amortization and cease use costs |
FinanceLeaseRightOfUseAssetAmortization
|
$244.00K | USD | 3 Qtrs |
| Right-of-use amortization and cease use costs |
FinanceLeaseRightOfUseAssetAmortization
|
$339.00K | USD | 3 Qtrs |
| Right-of-use amortization and cease use costs |
FinanceLeaseRightOfUseAssetAmortization
|
$339.00K | USD | 3 Qtrs |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$243.00K | USD | 3 Qtrs |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$243.00K | USD | 3 Qtrs |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$775.00K | USD | 3 Qtrs |
| Amortization of debt issuance costs |
AmortizationOfFinancingCosts
|
$775.00K | USD | 3 Qtrs |
| Deferred income taxes, net |
DeferredIncomeTaxesAndTaxCredits
|
$2.10M | USD | 3 Qtrs |
| Deferred income taxes, net |
DeferredIncomeTaxesAndTaxCredits
|
$2.10M | USD | 3 Qtrs |
| Deferred income taxes, net |
DeferredIncomeTaxesAndTaxCredits
|
$915.00K | USD | 3 Qtrs |
| Deferred income taxes, net |
DeferredIncomeTaxesAndTaxCredits
|
$915.00K | USD | 3 Qtrs |
| Unrealized net (gain) loss on warrants |
FairValueAdjustmentOfWarrants
|
$-178.00K | USD | 3 Qtrs |
| Unrealized net (gain) loss on warrants |
FairValueAdjustmentOfWarrants
|
$-178.00K | USD | 3 Qtrs |
| Unrealized net (gain) loss on warrants |
FairValueAdjustmentOfWarrants
|
$745.00K | USD | 3 Qtrs |
| Unrealized net (gain) loss on warrants |
FairValueAdjustmentOfWarrants
|
$745.00K | USD | 3 Qtrs |
| Net realized gain on exercise of warrants |
NetRealizedGainOnExerciseOfWarrants
|
- | USD | 3 Qtrs |
| Net realized gain on exercise of warrants |
NetRealizedGainOnExerciseOfWarrants
|
- | USD | 3 Qtrs |
| Net realized gain on exercise of warrants |
NetRealizedGainOnExerciseOfWarrants
|
$-495.00K | USD | 3 Qtrs |
| Net realized gain on exercise of warrants |
NetRealizedGainOnExerciseOfWarrants
|
$-495.00K | USD | 3 Qtrs |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 1 Quarter |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 3 Qtrs |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
- | USD | 3 Qtrs |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
$-228.00K | USD | 3 Qtrs |
| Realized loss from sale of assets |
GainLossOnDispositionOfAssets1
|
$-228.00K | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
|
$-4.90M | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
|
$-4.90M | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
|
- | USD | 3 Qtrs |
| Change in fair value of acquisition-related contingent consideration |
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
|
- | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 1 Quarter |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
- | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 3 Qtrs |
| Gain on revaluation of finance receivable |
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
|
$2.50M | USD | 3 Qtrs |
| Foreign currency transaction gain |
ForeignCurrencyTransactionGainBeforeTax
|
$375.00K | USD | 3 Qtrs |
| Foreign currency transaction gain |
ForeignCurrencyTransactionGainBeforeTax
|
$375.00K | USD | 3 Qtrs |
| Foreign currency transaction gain |
ForeignCurrencyTransactionGainBeforeTax
|
$459.00K | USD | 3 Qtrs |
| Foreign currency transaction gain |
ForeignCurrencyTransactionGainBeforeTax
|
$459.00K | USD | 3 Qtrs |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$-6.00K | USD | 1 Quarter |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$-6.00K | USD | 1 Quarter |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 1 Quarter |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 1 Quarter |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 3 Qtrs |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
- | USD | 3 Qtrs |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$12.00K | USD | 3 Qtrs |
| Unrealized gain on marketable investments |
MarketableSecuritiesUnrealizedGainLoss
|
$12.00K | USD | 3 Qtrs |
| Loan discount amortization and fee accretion |
AmortizationOfDeferredLoanOriginationFeesNet
|
$2.46M | USD | 3 Qtrs |
| Loan discount amortization and fee accretion |
AmortizationOfDeferredLoanOriginationFeesNet
|
$2.46M | USD | 3 Qtrs |
| Loan discount amortization and fee accretion |
AmortizationOfDeferredLoanOriginationFeesNet
|
$2.96M | USD | 3 Qtrs |
| Loan discount amortization and fee accretion |
AmortizationOfDeferredLoanOriginationFeesNet
|
$2.96M | USD | 3 Qtrs |
| Interest paid-in-kind |
PaidInKindInterestCapitzlied
|
$1.83M | USD | 3 Qtrs |
| Interest paid-in-kind |
PaidInKindInterestCapitzlied
|
$1.83M | USD | 3 Qtrs |
| Interest paid-in-kind |
PaidInKindInterestCapitzlied
|
$1.36M | USD | 3 Qtrs |
| Interest paid-in-kind |
PaidInKindInterestCapitzlied
|
$1.36M | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$369.00K | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$369.00K | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$708.00K | USD | 3 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$708.00K | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.94M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.94M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$652.00K | USD | 1 Quarter |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$652.00K | USD | 1 Quarter |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.17M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$1.17M | USD | 3 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$234.00K | USD | 1 Quarter |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$234.00K | USD | 1 Quarter |
| Interest, accounts receivable and other receivables |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$1.69M | USD | 3 Qtrs |
| Interest, accounts receivable and other receivables |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$1.69M | USD | 3 Qtrs |
| Interest, accounts receivable and other receivables |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$1.32M | USD | 3 Qtrs |
| Interest, accounts receivable and other receivables |
IncreaseDecreaseInAccountsAndOtherReceivables
|
$1.32M | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$-30.00K | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$-30.00K | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$738.00K | USD | 3 Qtrs |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$738.00K | USD | 3 Qtrs |
| Accounts payable, accrued expenses, and other non-current liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-1.40M | USD | 3 Qtrs |
| Accounts payable, accrued expenses, and other non-current liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-1.40M | USD | 3 Qtrs |
| Accounts payable, accrued expenses, and other non-current liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-632.00K | USD | 3 Qtrs |
| Accounts payable, accrued expenses, and other non-current liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-632.00K | USD | 3 Qtrs |
| Deferred income |
IncreaseDecreaseInDeferredRevenue
|
$-3.00K | USD | 3 Qtrs |
| Deferred income |
IncreaseDecreaseInDeferredRevenue
|
$-3.00K | USD | 3 Qtrs |
| Deferred income |
IncreaseDecreaseInDeferredRevenue
|
$2.10M | USD | 3 Qtrs |
| Deferred income |
IncreaseDecreaseInDeferredRevenue
|
$2.10M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$9.19M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$9.19M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$16.16M | USD | 3 Qtrs |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$16.16M | USD | 3 Qtrs |
| Sale of finance receivables |
ProceedsFromSaleOfEquitySecuritiesFvNi
|
- | USD | 3 Qtrs |
| Sale of finance receivables |
ProceedsFromSaleOfEquitySecuritiesFvNi
|
- | USD | 3 Qtrs |
| Sale of finance receivables |
ProceedsFromSaleOfEquitySecuritiesFvNi
|
$13.94M | USD | 3 Qtrs |
| Sale of finance receivables |
ProceedsFromSaleOfEquitySecuritiesFvNi
|
$13.94M | USD | 3 Qtrs |
| Investment in finance receivables |
PaymentsToAcquireFinanceReceivables
|
$17.52M | USD | 3 Qtrs |
| Investment in finance receivables |
PaymentsToAcquireFinanceReceivables
|
$17.52M | USD | 3 Qtrs |
| Investment in finance receivables |
PaymentsToAcquireFinanceReceivables
|
$17.74M | USD | 3 Qtrs |
| Investment in finance receivables |
PaymentsToAcquireFinanceReceivables
|
$17.74M | USD | 3 Qtrs |
| Sale of marketable investments |
ProceedsFromWarrantExercisesInvestingActivities
|
- | USD | 3 Qtrs |
| Sale of marketable investments |
ProceedsFromWarrantExercisesInvestingActivities
|
- | USD | 3 Qtrs |
| Sale of marketable investments |
ProceedsFromWarrantExercisesInvestingActivities
|
$574.00K | USD | 3 Qtrs |
| Sale of marketable investments |
ProceedsFromWarrantExercisesInvestingActivities
|
$574.00K | USD | 3 Qtrs |
| Repayment of finance receivables |
RepaymentOfFinanceReceivables
|
$7.43M | USD | 3 Qtrs |
| Repayment of finance receivables |
RepaymentOfFinanceReceivables
|
$7.43M | USD | 3 Qtrs |
| Repayment of finance receivables |
RepaymentOfFinanceReceivables
|
$30.58M | USD | 3 Qtrs |
| Repayment of finance receivables |
RepaymentOfFinanceReceivables
|
$30.58M | USD | 3 Qtrs |
| Corporate debt securities principal payments |
RepaymentOfCorporateDebtSecurities
|
$20.00K | USD | 3 Qtrs |
| Corporate debt securities principal payments |
RepaymentOfCorporateDebtSecurities
|
$20.00K | USD | 3 Qtrs |
| Corporate debt securities principal payments |
RepaymentOfCorporateDebtSecurities
|
$26.00K | USD | 3 Qtrs |
| Corporate debt securities principal payments |
RepaymentOfCorporateDebtSecurities
|
$26.00K | USD | 3 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$50.00K | USD | 3 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$50.00K | USD | 3 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$299.00K | USD | 3 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$299.00K | USD | 3 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$13.39M | USD | 3 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$13.39M | USD | 3 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$3.57M | USD | 3 Qtrs |
| Net cash provided by investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$3.57M | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
- | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
- | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$-43.00K | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$-43.00K | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$43.00K | USD | 1 Quarter |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$43.00K | USD | 1 Quarter |
| Net (payments on) proceeds from credit facility |
ProceedsFromRepaymentsOfLinesOfCredit
|
$-12.35M | USD | 3 Qtrs |
| Net (payments on) proceeds from credit facility |
ProceedsFromRepaymentsOfLinesOfCredit
|
$-12.35M | USD | 3 Qtrs |
| Net (payments on) proceeds from credit facility |
ProceedsFromRepaymentsOfLinesOfCredit
|
$19.55M | USD | 3 Qtrs |
| Net (payments on) proceeds from credit facility |
ProceedsFromRepaymentsOfLinesOfCredit
|
$19.55M | USD | 3 Qtrs |
| Payments for financing costs |
PaymentsOfFinancingCosts
|
$1.34M | USD | 3 Qtrs |
| Payments for financing costs |
PaymentsOfFinancingCosts
|
$1.34M | USD | 3 Qtrs |
| Payments for financing costs |
PaymentsOfFinancingCosts
|
$50.00K | USD | 3 Qtrs |
| Payments for financing costs |
PaymentsOfFinancingCosts
|
$50.00K | USD | 3 Qtrs |
| Repurchases of common stock, including fees and expenses |
PaymentsForRepurchaseOfCommonStock
|
$5.17M | USD | 3 Qtrs |
| Repurchases of common stock, including fees and expenses |
PaymentsForRepurchaseOfCommonStock
|
$5.17M | USD | 3 Qtrs |
| Repurchases of common stock, including fees and expenses |
PaymentsForRepurchaseOfCommonStock
|
$6.09M | USD | 3 Qtrs |
| Repurchases of common stock, including fees and expenses |
PaymentsForRepurchaseOfCommonStock
|
$6.09M | USD | 3 Qtrs |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-17.61M | USD | 3 Qtrs |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-17.61M | USD | 3 Qtrs |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$12.12M | USD | 3 Qtrs |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$12.12M | USD | 3 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$11.94M | USD | 3 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$11.94M | USD | 3 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$24.88M | USD | 3 Qtrs |
| Net increase in cash, cash equivalents, and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$24.88M | USD | 3 Qtrs |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$17.18M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$17.18M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.16M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.16M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$5.24M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$5.24M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$31.03M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$31.03M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$17.18M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$17.18M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.16M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.16M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$5.24M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$5.24M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$31.03M | USD | Point-in-time |
| Cash, cash equivalents, and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$31.03M | USD | Point-in-time |
| Derecognition of right-of-use assets and operating lease liabilities upon termination of lease |
DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease
|
$82.00K | USD | 3 Qtrs |
| Derecognition of right-of-use assets and operating lease liabilities upon termination of lease |
DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease
|
$82.00K | USD | 3 Qtrs |
| Derecognition of right-of-use assets and operating lease liabilities upon termination of lease |
DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease
|
- | USD | 3 Qtrs |
| Derecognition of right-of-use assets and operating lease liabilities upon termination of lease |
DerecognitionOfRightOfUseAssetsAndOperatingLeaseLiabilitiesUponTerminationOfLease
|
- | USD | 3 Qtrs |
| Fair value of warrants received with finance receivables |
FairValueOfWarrantsReceivedWithFinanceReceivables
|
$1.07M | USD | 3 Qtrs |
| Fair value of warrants received with finance receivables |
FairValueOfWarrantsReceivedWithFinanceReceivables
|
$1.07M | USD | 3 Qtrs |
| Fair value of warrants received with finance receivables |
FairValueOfWarrantsReceivedWithFinanceReceivables
|
$822.00K | USD | 3 Qtrs |
| Fair value of warrants received with finance receivables |
FairValueOfWarrantsReceivedWithFinanceReceivables
|
$822.00K | USD | 3 Qtrs |
Stockholders Equity
88 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance (in shares) |
CommonStockSharesOutstanding
|
12.26M | shares | Point-in-time |
| Beginning balance (in shares) |
CommonStockSharesOutstanding
|
12.26M | shares | Point-in-time |
| Beginning balance (in shares) |
CommonStockSharesOutstanding
|
12.50M | shares | Point-in-time |
| Beginning balance (in shares) |
CommonStockSharesOutstanding
|
12.50M | shares | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$277.56M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$277.56M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$273.88M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$273.88M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$274.38M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$274.38M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$279.93M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$279.93M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$280.31M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$280.31M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$283.43M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$283.43M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$282.83M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$282.83M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$279.89M | USD | Point-in-time |
| Beginning balance |
StockholdersEquity
|
$279.89M | USD | Point-in-time |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$35.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$35.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$164.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$164.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$170.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$170.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$249.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$249.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$111.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$111.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$348.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
$348.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$999.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$999.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$531.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$531.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$963.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$963.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$3.22M | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$3.22M | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$950.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$950.00K | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$4.60M | USD | 1 Quarter |
| Repurchases of common stock in open market |
StockRepurchasedDuringPeriodValue
|
$4.60M | USD | 1 Quarter |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
- | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
- | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$-43.00K | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$-43.00K | USD | 3 Qtrs |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$43.00K | USD | 1 Quarter |
| Net settlement for employee taxes on stock options |
NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions
|
$43.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.63M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.63M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$468.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$468.00K | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.93M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.93M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.47M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.68M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$3.68M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$4.15M | USD | 2 Qtrs |
| Net income |
NetIncomeLoss
|
$4.15M | USD | 2 Qtrs |
| Net income |
NetIncomeLoss
|
$7.62M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$7.62M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$13.04M | USD | 3 Qtrs |
| Net income |
NetIncomeLoss
|
$13.04M | USD | 3 Qtrs |
| Ending balance |
StockholdersEquity
|
$277.56M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$277.56M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$273.88M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$273.88M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$274.38M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$274.38M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$279.93M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$279.93M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$280.31M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$280.31M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$283.43M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$283.43M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$282.83M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$282.83M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$279.89M | USD | Point-in-time |
| Ending balance |
StockholdersEquity
|
$279.89M | USD | Point-in-time |
| Ending balance (in shares) |
CommonStockSharesOutstanding
|
12.26M | shares | Point-in-time |
| Ending balance (in shares) |
CommonStockSharesOutstanding
|
12.26M | shares | Point-in-time |
| Ending balance (in shares) |
CommonStockSharesOutstanding
|
12.50M | shares | Point-in-time |
| Ending balance (in shares) |
CommonStockSharesOutstanding
|
12.50M | shares | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.